Clinical Trial Update: AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 1/2 study of AGN-193408 SR for open-angle glaucoma and ocular hypertension, currently recruiting. Sponsored by A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AGN-193408 SR

Snippet

Sponsor: AbbVie | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: RECRUITING